Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
MEDICAL UNIVERSITY OF LODZ has floated a tender for Successive Delivery of Medicinal Products Containing Alirocumab, Rosuvastatin and Inclisiran for the Implementation of the Picolo-Fh Research Project. The project location is Poland and the tender is closing on 03 Feb 2025. The tender notice number is 356-2025, while the TOT Ref Number is 112549871. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Poland
Summary : Successive Delivery of Medicinal Products Containing Alirocumab, Rosuvastatin and Inclisiran for the Implementation of the Picolo-Fh Research Project
Deadline : 03 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 112549871
Document Ref. No. : 356-2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the order for this procedure is: Successive delivery of medicinal products containing alirocumab, rosuvastatin and inclisiran as part of the research project: "ComParison of InClisiran Or aLirOcumab to standard therapy in pediatric Familial Hypercholesterolemia - the
Document Type: Contract Notice
Reference Number: ZP/151/2024
Contract Type: supplies
Authority Type: body-pl
Doc Title: Successive delivery of medicinal products containing alirocumab, rosuvastatin and inclisiran for the implementation of the PICOLO-FH research project
Dispatch Date: 2024-12-31
Publish
Documents
Want To Bid in This Tender?
Get Local Agent Support in Poland and 60 More Countries.
View Tenders By
Sign in with Google